GLAUKOS Corp
Develops ophthalmic therapies and devices for glaucoma, corneal, and retinal diseases.
GKOS | NYSE
Overview
Corporate Details
- ISIN(s):
- US3773221029
- LEI:
- Country:
- United States of America
- Address:
- 1 GLAUKOS WAY, 92656 ALISO VIEJO
- Website:
- https://www.glaukos.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company focused on developing and commercializing novel therapies for chronic eye diseases. The company targets conditions such as glaucoma, corneal disorders, and retinal diseases. A pioneer in its field, particularly in Micro-Invasive Glaucoma Surgery (MIGS), Glaukos develops a portfolio of surgical devices, pharmaceuticals, and diagnostic tools. The company is committed to advancing the standard of care through significant investment in research and development, aiming to create transformative treatments. It also provides comprehensive clinical support, training, and educational resources for healthcare professionals and patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all GLAUKOS Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GLAUKOS Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GLAUKOS Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
